Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Biomarker Screening Protocol for Participants With Solid Tumors
A clinical trial update describes a biomarker screening protocol for participants with solid tumors, and the study has been terminated.
-
CLINICAL_TRIALS research · 2025-06-30Clinical Trial Update: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase II clinical study evaluating Utidelone Capsule (UTD2) in advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer; th…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules [Phase 1]
This Phase 1 trial evaluates increasing doses and different treatment schedules of the AKT inhibitor AZD5363 (ipatasertib) in patients with …
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Dose Escalation of Lapatinib With Paclitaxel in Ovarian Cancer [Phase 1]
Phase 1 dose-escalation study evaluating lapatinib in combination with paclitaxel for ovarian cancer; safety and tolerability results have b…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor [Phase 1]
Phase 1 trial evaluating carbon nanoparticle-loaded iron (CNSI-Fe(II)) in patients with advanced solid tumors has completed, with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Measuring Oncological Value of Exercise and Statin [Phase 3]
Phase 3 clinical trial assessing the oncological value of combining exercise with a statin across prostate, breast, kidney, and ovarian canc…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Surgery for Relapsed Ovarian Cancer in Precision [Phase 1, Phase 2]
A precision medicine-guided surgical approach for relapsed ovarian, fallopian tube, and primary peritoneal cancers is being explored in Phas…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Ovarian Cancer Radiomics Approach in CT Led Evaluation
This clinical trial update describes a radiomics-based CT imaging study for evaluating ovarian cancer, sponsored by Imperial College Healthc…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands
A study to develop and validate a risk prediction model for ovarian cancer among relatives of ovarian cancer probands. The research consider…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial [Phase 2]
A Phase 2 pilot trial at UC Irvine is evaluating repurposed riluzole for cancer-related cognitive impairment across multiple cancer types, w…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 4]
A Phase 4 interventional trial evaluating Avastin (bevacizumab) in advanced or metastatic ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Combined Program of Supervised Physical Exercise and Nutritional Counseling in Ovarian Cancer Patients on Frontline Maintenance Treatment With PARP Inhibitors [NA]
An ongoing study is investigating a combined program of supervised exercise and nutritional counseling for ovarian cancer patients on frontl…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
A Yonsei University-led clinical trial investigates diagnosing multiple cancers and monitoring minimal residual disease using blood-based, h…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: HS-10502 Combination Treatment in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial update for HS-10502 in patients with advanced solid tumors, including recurrent ovarian cancer and HER2-negative br…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer [NA]
This clinical trial update reports a planned study from Seoul National University Hospital evaluating proactive immune tolerance induction d…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer [Phase 3]
Phase 3 trial updating a comparison of Fluzoparib plus Bevacizumab with a dietary intervention versus Fluzoparib monotherapy as first-line m…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating ZEN003694 in combination with Talazoparib for recurrent ovarian cancer and related gynecologic cancer…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer
This Clinical Trials update shows a study evaluating minimally invasive interval debulking surgery for advanced ovarian cancer; the trial st…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating intensive locoregional chemoimmunotherapy with intranodal dendritic cell vaccines for recurrent ov…
-
CLINICAL_TRIALS other · 2025-06-19Clinical Trial Update: CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer [Phase 1]
Phase 1 trial evaluating CPI-0209 in combination with carboplatin for platinum-sensitive recurrent ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Ultrasound Training Program for Gynecologic Cancer Staging in Residents [NA]
An educational clinical trial update describes an ultrasound training program for gynecologic cancer staging intended for residents, coverin…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Ultrasound RF Data for Discriminating Between Benign and Malignant Ovarian Masses [NA]
This clinical trial update reports on an ongoing study (NCT06473766) sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCC…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: NeoVax With Nivolumab in Patients With Ovarian Cancer [Phase 1]
Phase 1 trial evaluating NeoVax in combination with nivolumab for ovarian cancer is currently active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: APG-2449 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of APG-2449 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, esophageal…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
This McGill University–sponsored clinical trial is evaluating a genomics-based approach for early diagnosis of ovarian and endometrial cance…